ticlopidine has been researched along with Papulosquamous Disorders in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with ticlopidine, a platelet-aggregation inhibitor (250 mg twice daily), was initiated and she has now been free of extracutaneous symptoms for 6 years." | 2.39 | [Malignant atrophic papulosis]. ( Aumiller, J; Kutzner, H; Ostendorf, PC; Saeger, W; Voigt, C, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voigt, C | 1 |
| Aumiller, J | 1 |
| Saeger, W | 1 |
| Kutzner, H | 1 |
| Ostendorf, PC | 1 |
1 review available for ticlopidine and Papulosquamous Disorders
| Article | Year |
|---|---|
[Malignant atrophic papulosis].
Topics: Biopsy; Combined Modality Therapy; Female; Humans; Intestinal Obstruction; Intestinal Perforation; J | 1994 |